Why Is PRIVIA HEALTH GROUP (PRVA) Stock Down Today?

Why PRVA stock is down today

PRVA stock is down 15.86% today, closing at $20.16. The sharp decline follows the company’s filing of a Form 8-K, which disclosed preliminary financial results and updated guidance for 2026. The report highlighted a non-GAAP EPS of $0.19, which missed estimates by $0.05, despite revenue of $632.6 million that beat expectations by $31.84 million. The mixed results have triggered a sell-off as investors reassess the company’s outlook.

What Happened

The 8-K filing included a summary of the company’s second-quarter financial performance and updated full-year guidance. The company reported a 21.4% year-over-year revenue increase to $632.6 million. However, the EPS shortfall and a net income of $9.0 million, up 236.7% from the prior year, failed to fully satisfy investor expectations. The filing also included updated 2026 revenue guidance, which remains within the $2.35 billion to $2.45 billion range. The mixed signals have led to a sharp selloff, with the stock opening at a 12.8% gap down from the previous close.

What The Data Shows

The stock opened at $20.90 and quickly fell to a session low of $19.80. Trading volume has been subdued at 0.2 million shares, which is 0.2 times the 3-month average. The stock is currently trading within its 52-week range of $19.08 to $28.82. Despite a 24.7% year-to-date revenue growth and a market cap of $3.0 billion, the company’s P/E ratio of 141.3 and a net margin of 1.0% highlight ongoing profitability challenges. The recent insider sales by the CFO and the mixed guidance have added to investor caution.

What To Watch

The company has not scheduled an earnings release for the near term. Investors should monitor coverage breadth and any further updates to guidance as the market digests the mixed earnings report and insider activity.